|
|
Bin Ren, Yong Deng, Arpita Mukhopadhyay, Anthony A. Lanahan, Zhen W. Zhuang, Karen L. Moodie, Mary Jo Mulligan-Kehoe, Tatiana V. Byzova, Randall T. Peterson, Michael Simons
J Clin Invest. 2010;
120(4):1217
doi:10.1172/JCI39837
Abstract |
Full text
| PDF
| Supplemental material

A
rterial morphogenesis is an important and poorly understood process. In particular, the signaling events controlling arterial formation have not been established. We evaluated whether alterations in the balance between ERK1/2 and PI3K signaling pathways could stimulate arterial formation in the setting of defective arterial morphogenesis in mice and zebrafish. Increased ERK1/2 activity in mouse ECs with reduced VEGF responsiveness was achieved in vitro and in vivo by downregulating PI3K activity, suppressing Akt1 but not Akt2 expression, or introducing a constitutively active ERK1/2 construct. Such restoration of ERK1/2 activation was sufficient to restore impaired arterial development and branching morphogenesis in synectin-deficient mice and synectin-knockdown zebrafish. The same approach effectively stimulated arterial growth in adult mice, restoring arteriogenesis in mice lacking synectin and in atherosclerotic mice lacking both LDL-R and ApoB48. We therefore conclude that PI3K-ERK1/2 crosstalk plays a key role in the regulation of arterial growth and that the augmentation of ERK signaling via suppression of the PI3K signaling pathway can effectively stimulate arteriogenesis.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(10)
| Title and authors |
Publication |
Year |
Systematic Approaches to Toxicology in the Zebrafish
Randall T. Peterson, Calum A. MacRae
|
Annu. Rev. Pharmacol. Toxicol.
|
2012 |
Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome?
Petra Rocic
|
Vascular Pharmacology
|
2012 |
Intracellular pH regulation by Na+/H+ exchanger-1 (NHE1) is required for growth factor-induced mammary branching morphogenesis
Edmund C. Jenkins, Shawon Debnath, Stephen Gundry, Sajini Gundry, Umit Uyar, Jimmie E. Fata
|
Developmental Biology
|
2012 |
FGF-dependent regulation of VEGF receptor 2 expression in mice
Masahiro Murakami, Loc T. Nguyen, Kunihiko Hatanaka, William Schachterle, Pei-Yu Chen, Zhen W. Zhuang, Brian L. Black, Michael Simons
|
J. Clin. Invest.
|
2011 |
Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway
B. Ren, J. Hale, S. Srikanthan, R. L. Silverstein
|
Blood
|
2011 |
Combinatory action of VEGFR2 and MAP kinase pathways maintains endothelial-cell integrity
Hanbing Zhong, Danyang Wang, Nan Wang, Yesenia Rios, Haigen Huang, Song Li, Xinrong Wu, Shuo Lin
|
Cell Res
|
2011 |
Methods in Cell Biology
Randall T. Peterson, Mark C. Fishman
|
Methods in Cell Biology Volume 105
|
2011 |
Coronary collateral growth—back to the future
William M. Chilian, Marc S. Penn, Yuh Fen Pung, Feng Dong, Maritza Mayorga, Vahagn Ohanyan, Suzanna Logan, Liya Yin
|
Journal of Molecular and Cellular Cardiology
|
2011 |
VEGF Receptor 2 Endocytic Trafficking Regulates Arterial Morphogenesis
Anthony A. Lanahan, Karlien Hermans, Filip Claes, Joanna S. Kerley-Hamilton, Zhen W. Zhuang, Frank J. Giordano, Peter Carmeliet, Michael Simons
|
Developmental Cell
|
2010 |
Small Molecule Screening in Zebrafish
David S. Peal, Randall T. Peterson, David Milan
|
J. of Cardiovasc. Trans. Res.
|
2010 |
|